[D-penicillamine in the treatment of progressive systemic sclerosis]. 1980

J F Marques Neto, and L C Manzato, and A M Samara

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

J F Marques Neto, and L C Manzato, and A M Samara
June 1976, The British journal of dermatology,
J F Marques Neto, and L C Manzato, and A M Samara
March 1982, The Journal of allergy and clinical immunology,
J F Marques Neto, and L C Manzato, and A M Samara
October 1991, The Journal of rheumatology,
J F Marques Neto, and L C Manzato, and A M Samara
January 1989, Scandinavian journal of rheumatology,
J F Marques Neto, and L C Manzato, and A M Samara
January 1981, The Journal of rheumatology. Supplement,
J F Marques Neto, and L C Manzato, and A M Samara
May 1983, Annals of internal medicine,
J F Marques Neto, and L C Manzato, and A M Samara
November 1982, Annals of internal medicine,
J F Marques Neto, and L C Manzato, and A M Samara
January 1986, Scandinavian journal of rheumatology,
J F Marques Neto, and L C Manzato, and A M Samara
February 1992, Internal medicine (Tokyo, Japan),
J F Marques Neto, and L C Manzato, and A M Samara
October 1990, International journal of dermatology,
Copied contents to your clipboard!